Epilepsy in neurodegenerative diseases: related drugs and molecular pathways
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/1822/74518 |
Resumo: | Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimers disease, Parkinsons disease, Huntingtons disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases. |
id |
RCAP_f0f10c70692cbd10004823ec347086bd |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/74518 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathwaysEpilepsyNeurodegenerative diseasesAlzheimers diseaseParkinsons diseaseHuntingtons diseaseMultiple sclerosisCiências Médicas::Biotecnologia MédicaScience & TechnologyEpilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimers disease, Parkinsons disease, Huntingtons disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.Acknowledges the support of the Spanish Ministry of Science, Innovation and Universities under the grant Juan de la Cierva (FJC2018-036012-I). Authors acknowledge the support of the Instituto de Salud Carlos III (ISCIII) Acción Estratégica en Salud, integrated into the Spanish National R+D+I Plan and financed by ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER “Una manera de hacer Europa”) grant PI17/01474 awarded to M.B. Boada and grant PI19/00335 awarded to M.M.; M.E. acknowledges the support of the Spanish Ministry of Economy and Competitiveness under the project SAF2017- 84283-R, and CIBERNED under project CB06/05/0024. E.B.S. acknowledges the support of the Portuguese Science and Technology Foundation (FCT) for the strategic fund (UIDB/04469/2020). A.R. acknowledges the support of CIBERNED (Instituto de Salud Carlos III (ISCIII)), the EU/EFPIA Innovative Medicines Initiative Joint Undertaking, ADAPTED Grant Nº 115975, from EXIT project, EU Euronanomed3 Program JCT2017 Grant Nº AC17/00100, from PREADAPT project. Joint Program for Neurodegenerative Diseases (JPND) Grant No. AC19/00097, and from grants PI13/02434, PI16/01861 BA19/00020, and PI19/01301. Acción Estratégica en Salud, integrated in the Spanish National RCDCI Plan and financed by Instituto de Salud Carlos III (ISCIII)- Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER—“Una manera de Hacer Europa”), by Fundación bancaria “La Caixa” and Grífols SA (GR@ACE project)info:eu-repo/semantics/publishedVersionMultidisciplinary Digital Publishing Institute (MDPI)Universidade do MinhoCano, AmandaFonseca, ElenaEttcheto, MirenSánchez-López, Elenade Rojas, ItziarAlonso-Lana, SilviaMorató, XavierSouto, Eliana B.Toledo, ManuelBoada, MercèMarquié, MartaRuíz, Agustín2021-10-182021-10-18T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/74518engCano, Amanda; Fonseca, Elena; Ettcheto, Miren; Sánchez-López, Elena; de Rojas, Itziar; Alonso-Lana, Silvia; Morató, Xavier; Souto, Eliana; Toledo, Manuel; Boada, Mercè; Marquié, Marta; Ruíz, Agustín, Epilepsy in neurodegenerative diseases: related drugs and molecular pathways. Pharmaceuticals, 14(10), 1057, 20211424-824710.3390/ph14101057https://www.mdpi.com/1424-8247/14/10/1057info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:04:23Zoai:repositorium.sdum.uminho.pt:1822/74518Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:54:41.055998Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways |
title |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways |
spellingShingle |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways Cano, Amanda Epilepsy Neurodegenerative diseases Alzheimers disease Parkinsons disease Huntingtons disease Multiple sclerosis Ciências Médicas::Biotecnologia Médica Science & Technology |
title_short |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways |
title_full |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways |
title_fullStr |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways |
title_full_unstemmed |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways |
title_sort |
Epilepsy in neurodegenerative diseases: related drugs and molecular pathways |
author |
Cano, Amanda |
author_facet |
Cano, Amanda Fonseca, Elena Ettcheto, Miren Sánchez-López, Elena de Rojas, Itziar Alonso-Lana, Silvia Morató, Xavier Souto, Eliana B. Toledo, Manuel Boada, Mercè Marquié, Marta Ruíz, Agustín |
author_role |
author |
author2 |
Fonseca, Elena Ettcheto, Miren Sánchez-López, Elena de Rojas, Itziar Alonso-Lana, Silvia Morató, Xavier Souto, Eliana B. Toledo, Manuel Boada, Mercè Marquié, Marta Ruíz, Agustín |
author2_role |
author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Cano, Amanda Fonseca, Elena Ettcheto, Miren Sánchez-López, Elena de Rojas, Itziar Alonso-Lana, Silvia Morató, Xavier Souto, Eliana B. Toledo, Manuel Boada, Mercè Marquié, Marta Ruíz, Agustín |
dc.subject.por.fl_str_mv |
Epilepsy Neurodegenerative diseases Alzheimers disease Parkinsons disease Huntingtons disease Multiple sclerosis Ciências Médicas::Biotecnologia Médica Science & Technology |
topic |
Epilepsy Neurodegenerative diseases Alzheimers disease Parkinsons disease Huntingtons disease Multiple sclerosis Ciências Médicas::Biotecnologia Médica Science & Technology |
description |
Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimers disease, Parkinsons disease, Huntingtons disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-10-18 2021-10-18T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1822/74518 |
url |
http://hdl.handle.net/1822/74518 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Cano, Amanda; Fonseca, Elena; Ettcheto, Miren; Sánchez-López, Elena; de Rojas, Itziar; Alonso-Lana, Silvia; Morató, Xavier; Souto, Eliana; Toledo, Manuel; Boada, Mercè; Marquié, Marta; Ruíz, Agustín, Epilepsy in neurodegenerative diseases: related drugs and molecular pathways. Pharmaceuticals, 14(10), 1057, 2021 1424-8247 10.3390/ph14101057 https://www.mdpi.com/1424-8247/14/10/1057 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132329622372352 |